Hospitals Ramp Up Hyperbaric Therapy For Diabetics, Despite Concerns
Medicare is trying to deter overuse of hyperbaric therapy, and some experts question its effectiveness for healing diabetic wounds, one of the treatment鈥檚 fastest-growing uses.
Health Industry
2,541 - 2,560 of 3,992 Results
-
-
Take Our Quiz To Test Your Wits On Aging
As we get older, it helps to tickle the noggin with trivia.聽Here's a pop quiz to see what you have learned as a regular reader of Kaiser Health News.
-
House Seeks To Cap Malpractice Awards As Part Of Health Care Update
The bill would limit non-economic damages to $250,000, but it faces opposition from across the political spectrum.
-
Repeal & Replace Watch
Senate And House Take Different Plans To Scrap Individual Mandate
The Republicans' penalty would affect people buying insurance who had a lapse in coverage of more than 63 days over a year.
By Jordan Rau and Anna Gorman -
In The End, Even The Middle Class Would Feel GOP Squeeze On Nursing Home Care
Medicaid pays for two-thirds of nursing home residents, but some recipients don鈥檛 even know they鈥檙e on it.
By Jordan Rau -
All Kids Should Be Screened for Obesity
An expert panel renews its guidelines that children and teens be screened for obesity at doctors鈥 offices and advised to receive treatment.
-
Survivors Of Childhood Diseases Struggle To Find Care As Adults
Once-fatal childhood diseases, like cystic fibrosis, congenital heart disease and sickle cell anemia, now can be survived into adulthood. But when those patients become too old to see pediatricians, it can be difficult for them to find physicians familiar with their conditions.
-
FDA Ruling On Aussie Biotech Could Boost Congressman鈥檚 Investment
Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.
By Rachel Bluth -
The New War On Sepsis
Armed with strict guidelines and motivated by sheer urgency, a specialized team of nurses makes the rounds, seeking to thwart the No. 1 killer in U.S. hospitals.
By Anna Gorman -
Despite A Growing Appetite, Buffet-Style Flat-Fee Clinics Shutter In Seattle
A small number of medical practices have been moving to 鈥渄irect primary care,鈥 in which patients pay a monthly retainer for unlimited services. But the collapse of Qliance in Seattle may portend problems with the business model.
-
Exclusive: White House Task Force Echoes Pharma Proposals
Documents examined by Kaiser Health News shed light on the workings of the Trump administration's 鈥淒rug Pricing and Innovation Working Group."
By Emily Kopp -
Widow Unleashes Court Fight Against Scope Maker Olympus Over Superbug Outbreak
The Seattle case, the first to reach trial in the U.S., offers possible glimpse into fate of some two dozen lawsuits against manufacturing giant Olympus, accused of failing to address scope contamination linked to numerous deaths. The company faults poor hospital cleaning practices.
By Chad Terhune and JoNel Aleccia -
Tweet Revenge: Twitter Erupts As Diabetes Forum Tries To Lock Down Photo Sharing
This year鈥檚 American Diabetes Association scientific meeting came with a hefty price 鈥 a policy of no photography and limits on social media. That did not go over well on Twitter.
By Emily Kopp -
Medical Responses To Opioid Addiction Vary By State, Analysis Finds
The study also found that the largest percentage of medical coverage claims related to opioid abuse and dependence nationally come from older patients 鈥 those ages 51 to 60.
-
鈥楬ow Long Have I Got, Doc?鈥 Why Many Cancer Patients Don鈥檛 Have Answers
Due to poor doctor-patient communication, most people with advanced cancer don鈥檛 know enough about their disease to make vital decisions.
By Liz Szabo -
Quantity Over Quality? Minorities Shown To Get An Excess Of Ineffective Care
The researchers looked at 11 services that medical groups have said are often unnecessary and found that Hispanics and blacks got them at higher rates than whites.
-
If Insurance Market Crashes, Can Lawmakers Put The Pieces Back Together?
Actions by the Trump administration are putting pressure on the fragile market for individuals who buy their own coverage, but analysts say it should be able to rebound.
By Julie Rovner -
Former Pharma Reps鈥 New Mission: To School Docs On High Drug Costs
One insurer is turning the tables on drugmakers with what may be a new job category: a sales force for cost-effective medicine.
By Jay Hancock -
Daylight On Diabetes Drugs: Nevada Bill Would Track Insulin Makers鈥 Profits
With the cost of medications up 300 percent in the past decade, supporters see this as a first step to rein in prices.
By Emily Kopp -
When An Insurer Balks And Treatment Stops
A 22-year old man from Orange County, Calif., alleges in a lawsuit that his health insurer stopped paying for a crucial 鈥 and expensive 鈥 immunotherapy drug, leading him to become seriously ill. Treatments for patients with similar conditions are increasingly denied or interrupted, experts and patient advocates say.
By Anna Gorman